Literature DB >> 11112837

Liver tumors.

M D Stringer1.   

Abstract

Liver tumors in children are rare, potentially complex, and encompass a broad spectrum of disease processes. Any age group may be affected, including the fetus. Most present with abdominal distension and/or a mass. Accurate preoperative diagnosis is usually possible using a combination of ultrasound scanning and cross-sectional imaging techniques (CT and/or MR), supplemented by liver biopsy and measurement of tumor markers. The most common benign tumors are hemangiomas, but mesenchymal hamartoma, focal nodular hyperplasia, and adenoma also are found. In Western countries, hepatoblastoma is the most common primary malignant liver tumor; disease-free survival is now possible in more than 80% of affected patients because of advances in combination chemotherapy, improved techniques of surgical resection, and the selective use of liver transplantation. In contrast, there has been less progress in the management of hepatocellular cancer, which still poses many therapeutic challenges. Copyright 2000 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2000        PMID: 11112837     DOI: 10.1053/spsu.2000.18844

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  4 in total

1.  Clinical characteristics and prognosis of pediatric hepatocellular carcinoma.

Authors:  Seung-Beom Yu; Hyun-Young Kim; Hong Eo; Jae-Kyung Won; Sung-Eun Jung; Kwi-Won Park; Woo-Ki Kim
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

2.  Hepatoblastomas in Oman: Unveiling success.

Authors:  Fatma Rabah; Nagwa El-Banna; Dipali Bhuyan; Ibrahim Al-Ghaithi; Mohamed Al-Hinai; Amal Al-Sabahi; Nawal Al-Mashaikhi; Ismail Beshlawi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

Review 3.  The role of liver transplantation in the management of paediatric liver tumours.

Authors:  Mark D Stringer
Journal:  Ann R Coll Surg Engl       Date:  2007-01       Impact factor: 1.891

4.  Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Rebecka L Meyers; Jon R Rowland; Mark Krailo; Zhengjia Chen; Howard M Katzenstein; Marcio H Malogolowkin
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.